Skip to main content
Premium Trial:

Request an Annual Quote

NINDS Awards Coriell Institute $7.7M to Support Biorepository

NEW YORK – The US National Institute of Neurological Disorders and Stroke (NINDS) has awarded Coriell Institute for Medical Research $7.7 million for ongoing support of its biorepository.

Under the terms of the five-year contract, Coriell will continue to support the NINDS Human Genetics Research Center. Camden, New Jersey-based Coriell has been the contractor for the NINDS center since its establishment in 2002.

NINDS' biorepository includes samples from subjects with various diseases, including cerebrovascular disease, dystonia, epilepsy, motor neuron disease, parkinsonism, and Tourette syndrome. It also collects demographic, clinical, and other genetic data, which it makes available to researchers globally.

According to Coriell, the new money will support sample processing as well as storage and distribution at the center, in addition to the expansion of resource sub-collections, such as those focused on cerebrovascular disease and dystonia.

The contract will also support work to link samples to genomic data stored in dbGAP, the database of National Institutes of Health Genotypes and Phenotypes.

The Scan

Support for Moderna Booster

An FDA advisory committee supports authorizing a booster for Moderna's SARS-CoV-2 vaccine, CNN reports.

Testing at UK Lab Suspended

SARS-CoV-2 testing at a UK lab has been suspended following a number of false negative results.

J&J CSO to Step Down

The Wall Street Journal reports that Paul Stoffels will be stepping down as chief scientific officer at Johnson & Johnson by the end of the year.

Science Papers Present Proteo-Genomic Map of Human Health, Brain Tumor Target, Tool to Infer CNVs

In Science this week: gene-protein-disease map, epigenomic and transcriptomic approach highlights potential therapeutic target for gliomas, and more